Jena, Germany

Sabine Gliesing

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006-2015

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sabine Gliesing to Pharmaceutical Development

Introduction

Sabine Gliesing, an accomplished inventor based in Jena, Germany, has made significant strides in the field of pharmaceutical development. With a total of six patents to her name, Gliesing’s innovative methods focus on the production of crystalline active ingredient particles, which are essential for the formulation of effective drugs.

Latest Patents

Her latest patents showcase groundbreaking techniques that have the potential to transform drug composition and delivery. One notable patent is titled "Method for producing crystalline active ingredient particles." This invention describes a method and device for generating crystalline active ingredient particles by crystallizing the active ingredient from a supersaturated solution on the surface of the particles. This process involves wet grinding in a supersaturated solution of the active ingredient and utilizing ultrasound in the subsequent cooling phase. The patent specifies that the resulting particles can have a mean size ranging from 10 to 500 micrometers, with a relative supersaturation of ≤90% in the liquid phase.

Another groundbreaking patent is focused on "Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs." This invention details a method for fabricating highly crystalline and stable microparticles that maintain a narrow size distribution. The newly formed microparticles are created from a suspension containing primary particles, a solution of the active substance, a non-solvent, and inert formed pieces. These microparticles demonstrate excellent stability, making them particularly suitable for fast-release pharmaceutical formulations.

Career Highlights

Throughout her career, Sabine Gliesing has contributed her expertise to prominent companies in the pharmaceutical sector, including Schering Aktiengesellschaft and Jesalis Pharma GmbH. Her innovative work has positioned her as a key figure in advancing methodologies for drug production.

Collaborations

Collaboration has been a crucial aspect of Gliesing’s career. She has worked alongside notable colleagues such as Detlef Grawe and Hagen Gerecke. Together, they have contributed to significant advancements in the field of pharmaceutical sciences, leveraging their combined expertise to innovate solutions that improve drug efficacy and safety.

Conclusion

Sabine Gliesing exemplifies the spirit of innovation in the pharmaceutical industry. Her commitment to the development of effective production methods for crystalline active ingredients has the potential to greatly enhance drug therapies. As she continues to build on her successes, Gliesing’s work promises to leave a lasting impact on pharmaceutical technology and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…